Researchers believe a once-daily shot of Sanofi-Aventis' insulin drug Lantus can control blood sugar levels in patients with type 2 diabetes just as effectively as three daily injections of Eli Lilly's Humalog. Following a Sanofi-Aventis-funded study that involved 400 people with type 2 diabetes, those who took Lantus saw a 1.7 percent decrease over time, compared to a 1.9 percent decrease in the group using Humalog.

Researchers concluded in their report that Lantus is indeed a simple and effective option to treat type 2 diabetes, since it was associated with a lower risk of hypoglycemia, fewer injections, less blood glucose self monitoring and greater patient satisfaction compared to Humalog

A French woman, with rare facial tumor and whose petition for euthanasia was earlier rejected by the court was found dead in her home on Wednesday. No details have been released on the cause of death of Chantal Sebire, diagnosed eight years ago with the rare disease of esthesioneuroblastoma (ENB).

According to the International Herald Tribune, a government official said in anonymity that Sebire died in her home at Plombieres-les-Dijon

At least 15,000 human kidneys a year are sold and obtained through organ trafficking and many medical professionals are turning a blind eye (and hand) on the practice.

At a United Nations Forum in Vienna, Austria, University of Berkeley Professor Nancy Scheper-Hughes accused surgeons and top medical professionals of being in league with criminal elements in targeting desperate transplant patients

A major government study has concluded that excessively low blood sugar levels in high-risk diabetes patients appears to increase the risk of dying from a heart attack or stroke.

Prompted by the study, the National Institutes of Health (NIH) immediately halted a massive trial of diabetes and heart disease citing a large number of deaths among patients who pushed their blood sugar level really low

U.S. plant geneticists and crop scientists have developed new and cheaper techniques to produce vitamin A-rich corn. The techniques also led them to discover a mutant gene responsible for making corn plants rich in vitamin A or retinol.

The innovation and discovery made by scientists from four different universities, Boyce Thompson Institute, DuPont Crop Genetics Research, the International Maize and Wheat Improvement Center and the U.S. Department of Agriculture can solve the problem of vitamin A deficiency of corn-eating populations in sub-Saharan Africa and America. Nutrition lacking in retinol is a major cause of blindness